No Picture
Trading Ideas

Zoom shares slip over security concerns, rising competition

Brokerage Credit Suisse downgraded Zoom Video Communications Inc’s stock to “underperform” from “neutral”. “While implied new customer growth may seem undemanding compared to recently disclosed 20x participant growth, we expect much of the recent surge will prove ephemeral, and/or comes from free users or education, which are very difficult to monetize,” Credit Suisse analysts wrote in a note. Last week, at least two U.S. state attorneys had sought information from Zoom following multiple reports that questioned its privacy and security. …read more […]

No Picture
Trading Ideas

Tenneco Soars 16% in Pre-Market Trading On Carl Icahn Stake Disclosure

Shares of Tenneco (TEN), a manufacturer of automotive products and solutions, are spiking over 16% in Monday’s pre-market trading. The move comes after hedge fund guru Carl Ichan disclosed acquiring over 3.48 million TEN shares on April 1.This is a volatile time for the stock. Shares plunged 21% on Friday after Tenneco withdrew its first-quarter and full-year guidance due to Covid-19 related uncertainty and suspended or reduced operations across several regions. In a press release, CEO Brian Kesseler commented: “The continuing near-term deterioration in demand in our end markets necessitates further difficult decisions.”As a result, JP Morgan’s Ryan Brinkman downgraded …read more […]

No Picture
Trading Ideas

IBM taps former Bank of America CTO to oversee cloud business

Arvind, known by his first name, headed the Big Blue’s fast-growing cloud business before his elevation as chief executive officer in late-January. As chief technology officer of Bank of America, Boville was responsible for building and running the second largest U.S. bank’s cloud services. IBM said in November it had created a financial services-specific cloud technology in collaboration with Bank of America. …read more […]

No Picture
Trading Ideas

3 Healthcare Stocks Fighting the Coronavirus

It’s a new week, and market watchers are bracing themselves for whatever comes their way. Ahead of the opening bell on Monday U.S. stock futures are up, some welcome news after stocks rounded out the week in the red. The uptick comes as Italy, Spain and New York report death rates are slowing, giving investors a sliver of hope that some headway is being made in the battle against COVID-19.For those feeling a sense of déjà vu, you’re not alone. Oanda’s senior market analyst for Asia Pacific, Jeffrey Halley, thinks the most recent bump might only be temporary, stating that …read more […]

No Picture
Trading Ideas

GSK to partner with Vir for potential COVID-19 treatments, invest $250 million

Drugmakers across the globe are rushing to develop a treatment or vaccine for the fast-spreading coronavirus that has killed over 68,400 people globally. There are currently no approved treatments for the disease. Initial focus will be to accelerate development of Vir’s investigational treatments, VIR-7831 and VIR-7832, the companies said. …read more […]

No Picture
Trading Ideas

Jamie Dimon Sees ‘Bad Recession’ and Echoes of 2008 Crisis Ahead

(Bloomberg) — Jamie Dimon said the coronavirus pandemic will lead to a major economic downturn and stress mirroring the meltdown that nearly brought down the U.S. financial system in 2008.“At a minimum, we assume that it will include a bad recession combined with some kind of financial stress similar to the global financial crisis of 2008,” the chief executive officer of JPMorgan Chase & Co. said Monday in his annual letter to shareholders. “Our bank cannot be immune to the effects of this kind of stress.”The 23-page letter, his shortest since 2008, came less than a week after Dimon told …read more […]

Healthcare

CytoDyn (OTC: CYDY) First Two Patients Enrolled in Randomized Phase 2, COVID-19 Trial with Leronlimab; Five More Severely Ill COVID-19 Patients Treated Under Emergency IND and Two Patients Have Already Extubated

Fifteen (15) severely ill COVID-19 patients have been treated under an EIND; 7-day results from the first four patients are available and are very promising; 7-day results for the first 10 patients will be available […]